Literature DB >> 33313997

Molecular probes for the human adenosine receptors.

Xue Yang1, Laura H Heitman1, Adriaan P IJzerman1, Daan van der Es2.   

Abstract

Adenosine receptors, G protein-coupled receptors (GPCRs) that are activated by the endogenous ligand adenosine, have been considered potential therapeutic targets in several disorders. To date however, only very few adenosine receptor modulators have made it to the market. Increased understanding of these receptors is required to improve the success rate of adenosine receptor drug discovery. To improve our understanding of receptor structure and function, over the past decades, a diverse array of molecular probes has been developed and applied. These probes, including radioactive or fluorescent moieties, have proven invaluable in GPCR research in general. Specifically for adenosine receptors, the development and application of covalent or reversible probes, whether radiolabeled or fluorescent, have been instrumental in the discovery of new chemical entities, the characterization and interrogation of adenosine receptor subtypes, and the study of adenosine receptor behavior in physiological and pathophysiological conditions. This review summarizes these applications, and also serves as an invitation to walk another mile to further improve probe characteristics and develop additional tags that allow the investigation of adenosine receptors and other GPCRs in even finer detail.

Entities:  

Keywords:  Adenosine receptors; Chemical biology; Covalent ligands; Fluorescent ligands; GPCR; PET ligands; Probes; Radioligands

Mesh:

Substances:

Year:  2020        PMID: 33313997      PMCID: PMC7954947          DOI: 10.1007/s11302-020-09753-8

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  130 in total

1.  Profiling enzyme activities in vivo using click chemistry methods.

Authors:  Anna E Speers; Benjamin F Cravatt
Journal:  Chem Biol       Date:  2004-04

Review 2.  Adenosine receptors as therapeutic targets.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

Review 3.  Activity-based protein profiling: from enzyme chemistry to proteomic chemistry.

Authors:  Benjamin F Cravatt; Aaron T Wright; John W Kozarich
Journal:  Annu Rev Biochem       Date:  2008       Impact factor: 23.643

Review 4.  Ligand binding assays at equilibrium: validation and interpretation.

Authors:  Edward C Hulme; Mike A Trevethick
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

5.  Structure of the Adenosine A1 Receptor Reveals the Basis for Subtype Selectivity.

Authors:  Alisa Glukhova; David M Thal; Anh T Nguyen; Elizabeth A Vecchio; Manuela Jörg; Peter J Scammells; Lauren T May; Patrick M Sexton; Arthur Christopoulos
Journal:  Cell       Date:  2017-02-23       Impact factor: 41.582

6.  Characterization of [3H]LUF5834: A novel non-ribose high-affinity agonist radioligand for the adenosine A1 receptor.

Authors:  J Robert Lane; Elisabeth Klaasse; Judy Lin; John van Bruchem; Margot W Beukers; Adriaan P Ijzerman
Journal:  Biochem Pharmacol       Date:  2010-06-30       Impact factor: 5.858

7.  The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.

Authors:  Veli-Pekka Jaakola; Mark T Griffith; Michael A Hanson; Vadim Cherezov; Ellen Y T Chien; J Robert Lane; Adriaan P Ijzerman; Raymond C Stevens
Journal:  Science       Date:  2008-10-02       Impact factor: 47.728

8.  Clickable Photoaffinity Ligands for Metabotropic Glutamate Receptor 5 Based on Select Acetylenic Negative Allosteric Modulators.

Authors:  Karen J Gregory; Ranganadh Velagaleti; David M Thal; Ryan M Brady; Arthur Christopoulos; P Jeffrey Conn; David J Lapinsky
Journal:  ACS Chem Biol       Date:  2016-05-04       Impact factor: 5.100

9.  Selective Photoaffinity Probe That Enables Assessment of Cannabinoid CB2 Receptor Expression and Ligand Engagement in Human Cells.

Authors:  Marjolein Soethoudt; Sara C Stolze; Matthias V Westphal; Luuk van Stralen; Andrea Martella; Eva J van Rooden; Wolfgang Guba; Zoltan V Varga; Hui Deng; Sander I van Kasteren; Uwe Grether; Adriaan P IJzerman; Pal Pacher; Erick M Carreira; Herman S Overkleeft; Andreea Ioan-Facsinay; Laura H Heitman; Mario van der Stelt
Journal:  J Am Chem Soc       Date:  2018-02-16       Impact factor: 15.419

10.  An Affinity-Based Probe for the Human Adenosine A2A Receptor.

Authors:  Xue Yang; Thomas J M Michiels; Coen de Jong; Marjolein Soethoudt; Niek Dekker; Euan Gordon; Mario van der Stelt; Laura H Heitman; Daan van der Es; Adriaan P IJzerman
Journal:  J Med Chem       Date:  2018-08-21       Impact factor: 7.446

View more
  3 in total

1.  Development of subtype-selective covalent ligands for the adenosine A2B receptor by tuning the reactive group.

Authors:  Bert L H Beerkens; Xuesong Wang; Maria Avgeropoulou; Lisa N Adistia; Jacobus P D van Veldhoven; Willem Jespers; Rongfang Liu; Laura H Heitman; Adriaan P IJzerman; Daan van der Es
Journal:  RSC Med Chem       Date:  2022-06-21

2.  Selective A3 Adenosine Receptor Antagonist Radioligand for Human and Rodent Species.

Authors:  R Rama Suresh; Zhan-Guo Gao; Veronica Salmaso; Eric Chen; Ryan G Campbell; Russell B Poe; Theodore E Liston; Kenneth A Jacobson
Journal:  ACS Med Chem Lett       Date:  2022-03-02       Impact factor: 4.632

3.  Single Stabilizing Point Mutation Enables High-Resolution Co-Crystal Structures of the Adenosine A2A Receptor with Preladenant Conjugates.

Authors:  Tobias Claff; Tim A Klapschinski; Udaya K Tiruttani Subhramanyam; Victoria J Vaaßen; Jonathan G Schlegel; Christin Vielmuth; Jan H Voß; Jörg Labahn; Christa E Müller
Journal:  Angew Chem Int Ed Engl       Date:  2022-03-24       Impact factor: 16.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.